Biogen (BIIB)

Total Costs & Expenses

$2.42B

Quarterly · Period ending: · USD

BIIB logo

BIIB Total Costs & Expenses

Latest reported$2.42B
BIIB Quarterly Total Costs & Expenses ($4.00M → $2.42B)
High-resolution chart · PNG

BIIB total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
2,417,900,000
2,080,400,000
2,336,300,000
1,841,000,000
2,057,400,000
1,698,400,000
1,945,700,000
1,888,600,000
2,098,400,000
1,600,100,000
1,873,900,000
2,209,500,000
1,766,300,000
1,888,600,000
1,985,700,000
1,638,500,000
1,652,700,000
2,007,400,000
2,226,900,000
1,979,300,000
2,304,200,000
1,720,100,000
3,183,200,000
2,289,700,000
1,707,100,000
1,714,400,000
1,893,600,000
1,793,800,000
1,660,800,000
1,987,100,000
2,083,200,000
1,741,400,000
2,143,300,000
1,596,400,000
1,840,800,000
1,423,900,000
1,877,400,000
1,786,000,000
1,985,800,000
1,530,500,000
1,433,700,000
1,348,400,000
1,671,100,000
1,406,100,000
1,358,500,000
1,437,000,000
1,480,902,000
1,358,868,000
1,432,727,000
1,458,403,000
1,307,924,000
1,143,249,000
1,065,863,000
915,639,000
982,973,000
-574,594,000
915,228,000
922,644,000
917,607,000
554,970,000
797,834,000
787,059,000
863,886,000
981,654,000
816,822,000
805,171,000
743,678,000
736,340,000
870,375,000
731,526,000
743,953,000
747,114,000
696,647,000
696,182,000
630,870,000
660,021,000
566,736,000
534,218,000
-294,241,000
506,164,000
782,056,000
438,186,000
-169,327,000
575,046,000
559,333,000
512,528,000
-85,880,000
472,443,000
540,233,000
625,607,000
793,461,000
67,129,000
80,418,000
54,104,000
220,181,000
219,247,000
217,124,000
195,175,000
187,494,000
175,606,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.